In the article “Update to acne vulgaris treatment for Canadian practice,” which appeared in the July/August 2025 issue of Canadian Family Physician,1 the contraindications column in Table 3 on page 461 for fixed-dose combinations 1% clindamycin and 5% benzoyl peroxide (BP), 1% clindamycin and 3% BP, 3% erythromycin and 5% BP, and 0.025% tretinoin and 1.2% clindamycin should have read, “None.”

The online version of this article has been corrected.